These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 35678602)

  • 21. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
    Minami S; Kotaki T; Sakai Y; Okamura S; Torii S; Ono C; Motooka D; Hamajima R; Nouda R; Nurdin JA; Yamasaki M; Kanai Y; Ebina H; Maeda Y; Okamoto T; Tachibana T; Matsuura Y; Kobayashi T
    Microbiol Spectr; 2024 Apr; 12(4):e0285923. PubMed ID: 38415690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
    Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination.
    Hossain MG; Tang YD; Akter S; Zheng C
    J Med Virol; 2022 May; 94(5):1815-1820. PubMed ID: 34936124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: Effects on proteolytic cleavage and ACE2 binding.
    Spelios MG; Capanelli JM; Li AW
    Immunol Lett; 2022 Feb; 242():1-7. PubMed ID: 35007661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
    Hoffmann M; Kleine-Weber H; Pöhlmann S
    Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2.
    Thaingtamtanha T; Baeurle SA
    J Mol Model; 2022 Jul; 28(8):224. PubMed ID: 35854129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing.
    Yamamoto Y; Inoue T; Inoue M; Murae M; Fukasawa M; Kaneko MK; Kato Y; Noguchi K
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.
    Khatri R; Lohiya B; Kaur G; Maithil V; Goswami A; Sarmadhikari D; Asthana S; Samal S
    3 Biotech; 2023 Oct; 13(10):323. PubMed ID: 37663753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
    Nguyen HT; Zhang S; Wang Q; Anang S; Wang J; Ding H; Kappes JC; Sodroski J
    J Virol; 2021 Mar; 95(5):. PubMed ID: 33310888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A second functional furin site in the SARS-CoV-2 spike protein.
    Zhang Y; Zhang L; Wu J; Yu Y; Liu S; Li T; Li Q; Ding R; Wang H; Nie J; Cui Z; Wang Y; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):182-194. PubMed ID: 34856891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of host proteases in the entry of SARS-CoV-2.
    Zabiegala A; Kim Y; Chang KO
    Anim Dis; 2023; 3(1):12. PubMed ID: 37128508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
    Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
    J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry.
    Follis KE; York J; Nunberg JH
    Virology; 2006 Jul; 350(2):358-69. PubMed ID: 16519916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.
    Örd M; Faustova I; Loog M
    Sci Rep; 2020 Oct; 10(1):16944. PubMed ID: 33037310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
    J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.
    Reuter N; Chen X; Kropff B; Peter AS; Britt WJ; Mach M; Überla K; Thomas M
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.